Ethan Y Lin1, A Kyle Jones2, Gouthami Chintalapani3, Zachary S Jeng4, Joe Ensor5, Bruno C Odisio6. 1. Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. 2. Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. 3. Siemens Medical Solutions USA Inc., 2501 North Barrington Road, Hoffman Estates, IL, 60192, USA. 4. Department of Radiology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030, USA. 5. The Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX, 77030, USA. 6. Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. BCOdisio@mdanderson.org.
Abstract
PURPOSE: To compare the imaging characteristics of intra-arterial cone-beam computed tomography during hepatic arteriography (CBCTHA) versus intra-arterial computed tomography during hepatic arteriography (CTHA) for intraprocedural transarterial chemoembolization (TACE) planning. MATERIALS AND METHODS: This single-institution retrospective study included 144 patients (96 men, mean age 67.9 years; 48 women, mean age 62.3 years) who underwent 181 TACE sessions between January 2015 and July 2017. Intraprocedural CBCTHA (111 procedures) or CTHA (70 procedures) was performed for TACE planning. Reformatted maximum intensity projection CBCTHA and CTHA images were reviewed by two radiologists and classified using an ordinal scoring system (for tumor identification, tumor feeder vessel identification, and streaking artifact) and a binary scoring system (for the presence of breathing motion artifact and field of view encompassing the entire liver). Data were analyzed using an F test and a z-score test. RESULTS: There were no significant differences in demographic and tumor characteristics between the CBCTHA and CTHA patient cohorts. CTHA was superior to CBCTHA for tumor identification (P < .0001), tumor feeder vessel identification (P < .05), streaking artifact (P < .0001), and field of view encompassing the entire liver (P < .0001). There was a trend toward a lower frequency of breathing motion artifact with CTHA than with CBCTHA (1.4% vs. 10%; P = .057). CONCLUSION: CTHA provides improved clinical relevant imaging information compared to CBCTHA for intraprocedural TACE planning. LEVEL OF EVIDENCE: Level III, retrospective comparative study.
PURPOSE: To compare the imaging characteristics of intra-arterial cone-beam computed tomography during hepatic arteriography (CBCTHA) versus intra-arterial computed tomography during hepatic arteriography (CTHA) for intraprocedural transarterial chemoembolization (TACE) planning. MATERIALS AND METHODS: This single-institution retrospective study included 144 patients (96 men, mean age 67.9 years; 48 women, mean age 62.3 years) who underwent 181 TACE sessions between January 2015 and July 2017. Intraprocedural CBCTHA (111 procedures) or CTHA (70 procedures) was performed for TACE planning. Reformatted maximum intensity projection CBCTHA and CTHA images were reviewed by two radiologists and classified using an ordinal scoring system (for tumor identification, tumor feeder vessel identification, and streaking artifact) and a binary scoring system (for the presence of breathing motion artifact and field of view encompassing the entire liver). Data were analyzed using an F test and a z-score test. RESULTS: There were no significant differences in demographic and tumor characteristics between the CBCTHA and CTHA patient cohorts. CTHA was superior to CBCTHA for tumor identification (P < .0001), tumor feeder vessel identification (P < .05), streaking artifact (P < .0001), and field of view encompassing the entire liver (P < .0001). There was a trend toward a lower frequency of breathing motion artifact with CTHA than with CBCTHA (1.4% vs. 10%; P = .057). CONCLUSION: CTHA provides improved clinical relevant imaging information compared to CBCTHA for intraprocedural TACE planning. LEVEL OF EVIDENCE: Level III, retrospective comparative study.
Authors: Ece Meram; Gabe Shaughnessy; Colin Longhurst; Carson Hoffman; Martin Wagner; Charles A Mistretta; Michael A Speidel; Paul F Laeseke Journal: Eur Radiol Exp Date: 2020-07-02